Role of the C-10 substituent in mitomycin C-1-DNA bonding

Journal of the American Chemical Society

Volumn 118, Issue 10, 1996, Pages 2326-2331

  Li, Ven Shun ^a   Choi, Daeock ^a   Wang, Zheng ^b   Jimenez, Leslie S ^b   Tang, Moon Shong ^c   Kohn, Harold ^a  

^a University of Houston   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; MITOMYCIN DERIVATIVE;

ARTICLE; DNA BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0029926963     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja953871v     Document Type: Article

References (40)

1. (a) Warpehoski, M. A.; Hurley, L. H. Chem. Res. Toxicol. 1988. 1, 315-333.
2. (b) Searle, M. Prog. Nucl. Magn. Reson. Spectrosc. 1993, 25, 403-480.
3. Carter, S. K.; Crooke, S. T. Mitomycin C. Current Status and New Developments; Academic Press: New York, 1979.
4. For leading reviews see: (a) Iyer, V. N.V.; Szybalski, W. Science 1964, 145, 55-58. (b) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. (c) Remers, W. A. The Chemisty of Antitumor Antibiotics; Wiley: New York, 1979; Vol. 1, pp 221-276. (d) Franck, R. W.; Tomasz, M. In The Chemistry of Antitumor Agents: Wilman, D. E. V., Ed.; Blackie and Sons, Ltd.: Glasgow. Scotland, 1990; pp 379-394. (e) Fisher, J. R.; Aristoff, P. A. Prog. Drug Res. 1988, 32, 411-498. (f) Tomasz, M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL. 1994; Vol. 2, pp 312-348.
5. For leading reviews see: (a) Iyer, V. N.V.; Szybalski, W. Science 1964, 145, 55-58. (b) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. (c) Remers, W. A. The Chemisty of Antitumor Antibiotics; Wiley: New York, 1979; Vol. 1, pp 221-276. (d) Franck, R. W.; Tomasz, M. In The Chemistry of Antitumor Agents: Wilman, D. E. V., Ed.; Blackie and Sons, Ltd.: Glasgow. Scotland, 1990; pp 379-394. (e) Fisher, J. R.; Aristoff, P. A. Prog. Drug Res. 1988, 32, 411-498. (f) Tomasz, M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL. 1994; Vol. 2, pp 312-348.
6. For leading reviews see: (a) Iyer, V. N.V.; Szybalski, W. Science 1964, 145, 55-58. (b) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. (c) Remers, W. A. The Chemisty of Antitumor Antibiotics; Wiley: New York, 1979; Vol. 1, pp 221-276. (d) Franck, R. W.; Tomasz, M. In The Chemistry of Antitumor Agents: Wilman, D. E. V., Ed.; Blackie and Sons, Ltd.: Glasgow. Scotland, 1990; pp 379-394. (e) Fisher, J. R.; Aristoff, P. A. Prog. Drug Res. 1988, 32, 411-498. (f) Tomasz, M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL. 1994; Vol. 2, pp 312-348.
7. For leading reviews see: (a) Iyer, V. N.V.; Szybalski, W. Science 1964, 145, 55-58. (b) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. (c) Remers, W. A. The Chemisty of Antitumor Antibiotics; Wiley: New York, 1979; Vol. 1, pp 221-276. (d) Franck, R. W.; Tomasz, M. In The Chemistry of Antitumor Agents: Wilman, D. E. V., Ed.; Blackie and Sons, Ltd.: Glasgow. Scotland, 1990; pp 379-394. (e) Fisher, J. R.; Aristoff, P. A. Prog. Drug Res. 1988, 32, 411-498. (f) Tomasz, M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL. 1994; Vol. 2, pp 312-348.
8. For leading reviews see: (a) Iyer, V. N.V.; Szybalski, W. Science 1964, 145, 55-58. (b) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. (c) Remers, W. A. The Chemisty of Antitumor Antibiotics; Wiley: New York, 1979; Vol. 1, pp 221-276. (d) Franck, R. W.; Tomasz, M. In The Chemistry of Antitumor Agents: Wilman, D. E. V., Ed.; Blackie and Sons, Ltd.: Glasgow. Scotland, 1990; pp 379-394. (e) Fisher, J. R.; Aristoff, P. A. Prog. Drug Res. 1988, 32, 411-498. (f) Tomasz, M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL. 1994; Vol. 2, pp 312-348.
9. For leading reviews see: (a) Iyer, V. N.V.; Szybalski, W. Science 1964, 145, 55-58. (b) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. (c) Remers, W. A. The Chemisty of Antitumor Antibiotics; Wiley: New York, 1979; Vol. 1, pp 221-276. (d) Franck, R. W.; Tomasz, M. In The Chemistry of Antitumor Agents: Wilman, D. E. V., Ed.; Blackie and Sons, Ltd.: Glasgow. Scotland, 1990; pp 379-394. (e) Fisher, J. R.; Aristoff, P. A. Prog. Drug Res. 1988, 32, 411-498. (f) Tomasz, M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds; Macmillan: Boca Raton, FL. 1994; Vol. 2, pp 312-348.
10. Li, V.-S.; Kohn, H. J. Am. Chem. Soc. 1991, 113, 275-283.
11. Kumar, S.; Lipman, R.; Tomasz, M. Biochemistry 1992, 31, 1399-1407.
12. Kohn, H.: Li, V.-S.; Tang, M.-s. J. Am. Chem. Soc. 1992, 114, 5501-5509.
13. Teng, S. P.; Woodson, S. A.; Crothers, D. M. Biochemistry 1989, 28, 3901-3907.
14. (a) Weidner, M. F.; Millard, J. T.: Hopkins, P. B. J. Am. Chem. Soc. 1989, 111, 9270-9272.
15. (b) Millard, J. T.; Weidner, M. F.; Raucher, S.; Hopkins, P. B. J. Am. Chem. Soc. 1990, 112, 3637-3641.
16. (c) Weidner, M. F.; Signurdsson, S. T.; Hopkins, P. B. Biochemistry 1990, 29, 9225-9233.
17. (a) Borowy-Borowski, H.: Lipman, R.; Tomasz, M. Biochemistiy 1990, 29, 2999-3006.
18. (b) Tomasz, M.; Lipman, R.; Chowdary, D.; Pawlak, J.: Verdine, G. L.; Nakanishi, K. Science 1987, 235, 1204-1208.
19. Remers, W. A.; Rao, S. N.; Wunz, T. P.; Kollman, P. A. J. Med. Chem. 1988, 31, 1612-1620.
20. Choi, D.; Yoo, B.; Colson, K. L.: Martin, G. E.; Kohn, H. J. Org. Chem. 1995, 60, 3391-3396.
21. Danishefsky, S. J.: Eabertson, M. J. Am. Chem. Soc. 1986, 108, 4648-4650.
22. Wans, Z.: Jimenez, L. S. J. Org. Chem. 1996, 61, 816-818.
23. Kohn, H.; Li, V.-S.; Schiltz, P.; Tang, M.-s. J. Am. Chem. Soc. 1992, 114, 9218-9220.
24. Li, V.-S.; Choi, D.; Tang, M.-s.; Kohn, H. J. Am. Chem. Soc., submitted for publication.
25. Li, V.-S.; Choi, D.; Tang, M.-s.; Kohn, H. Biochemistry 1995, 34, 7120-7126.
26. Friedberg, E. C.; Walker, G. C.; Siede, W. DNA Repair and Mutagenesis; ASM Press: Washington, DC, 1995.
27. Sancar, A.: Tang, M.-s. Photochem. Photobiol. 1993, 57, 905-921.
28. (a) Phillips, D. R.; White, R. J.; Cullinane, C. FEES 1989, 246, 233-240.
29. (b) McGuinness, B. F.; Liprman, R.; Goldstein, J.; Nakanishi, K.; Tomasz, M. Biochemistry 1991, 30, 6444-6453.
30. Tomasz, M.: Mercado, C. M.: Olson, J.: Chatterjie, N. Biochemistry 1974, 13, 4878-4887.
31. (a) Schlitz, P.: Kohn, H. J. Am. Chem. Soc. 1993, 115, 10497-10509.
32. (b) Schultz, P.: Kohn, H. Tetrahedron Lett. 1992, 33, 4709-4712.
33. Baker, E. N.: Hubbard, R. E. Prog. Biophys. Mol. 1984, 44, 97-179.
34. For a similar study, see: Chen, J. X.; Pao, A.; Zheng, Y.; Ye, X.; Kisleyou, A.: Morris, R.; Slaga, T. J.; Harvey, R.; Tang, M.-s. Cancer Res., submitted for publication.
35. Van Houten, B. Microbiol. Rev. 1990, 54, 18-51.
36. Sastry, M.; Fiala, R.; Lipman, R.; Tomasz, M.; Patel, D. J. J. Mol Biol. 1995, 247, 338-359.
37. Thomas, D. C.; Levy, M.; Sancar, A. J. Biol. Chem. 1985, 260, 9875-9883.
38. Tang, M.-s.; Nazimiec, M. E.; Doisy, R. P.: Pierce, J. R.; Hurley, L. H.; Alderete. B. E. J. Mol. Biol. 1991, 220, 855-866.
39. (a) Maxam, A. M.; Gilbert, W. Methods Enzymal. 1980, 65, 499-560.
40. (b) Maxam, A. M.; Gilbert, W. Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 560-564.